NKTR — NEKTAR THERAPEUTICS COM

Ownership history in Quantbot Technologies LP  ·  18 quarters on record

This page tracks every 13F SEC filing in which Quantbot Technologies LP reported a position in NEKTAR THERAPEUTICS COM (NKTR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.1% (2014 Q3)
Avg. % of fund
0.02%
First filed
2011 Q1
Last filed
2025 Q3
Quarters held
18
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 88 -20,864 -99.6% 0.00% $5K $56.90
2023 Q2 REDUCED 20,952 -26,644 -56.0% 0.00% $12K $8.70
2022 Q3 ADDED 47,596 +44,690 +1537.9% 0.01% $152K $48.00
2022 Q2 ADDED 2,906 +2,706 +1353.0% 0.00% $11K $57.00
14 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    NKTR price (monthly, adj. close)

Other funds also holding NKTR

As of 2025 Q4 — sorted by position size

22NW, LP 3Y 7Y 5.89% Prosight Management, LP 3Y 7Y 4.85% Propel Bio Management, LLC 2.99% GREAT POINT PARTNERS LLC 3Y 7Y 2.89% Stonepine Capital Management, LLC 3Y 7Y 2.62% Deuterium Capital Management, LLC 3Y 2.29% Monashee Investment Management LLC 3Y 7Y 2.24% BVF INC/IL 3Y 7Y 2.22% Stonepine Capital Management, LLC 3Y 7Y 1.54% STEMPOINT CAPITAL LP 1.29%
← Back to Quantbot Technologies LP Holdings